On November 10, 2023, the Board of Directors (the ?Board?) of the Eyenovia, Inc. appointed Michael Geltzeiler to serve on the Board and as the Chair of the Audit Committee of the Board (the ?Audit Committee?), in each case, effective November 14, 2023. Mr. Geltzeiler will serve as a director until the Company?s 2024 annual meeting of stockholders and thereafter until his successor has been elected and qualified or until his earlier death, resignation or removal.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.872 USD | +13.50% | +46.78% | -58.08% |
01/07 | NovaBay Pharmaceuticals, Eyenovia Begin Co-Promotion Deal Activities | MT |
01/07 | NovaBay Pharmaceuticals, Inc. and Eyenovia, Inc. Commence Co-Promotion Activities | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.08% | 4.72Cr | |
+56.89% | 81TCr | |
+39.52% | 62TCr | |
-6.55% | 35TCr | |
+7.92% | 29TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr | |
-2.57% | 16TCr |
- Stock Market
- Equities
- EYEN Stock
- News Eyenovia, Inc.
- Eyenovia, Inc. Appoints Michael Geltzeiler to Serve on the Board and as the Chair of the Audit Committee of the Board